Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  BASF    BAS   DE000BASF111

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

BASF SE : Rothamsted Research Biotech Experiment Reaps 8% More Oil From Rapeseed

share with twitter share with LinkedIn share with facebook
share via e-mail
11/22/2012 | 06:39pm CEST

By Michael Haddon

Rothamsted Research said Thursday it had successfully performed an experiment which accumulated around 8% more oil from rapeseed by using biotechnology to switch off an enzyme responsible for oil breakdown for the duration of seed development.

The agricultural research centre said further work is required to establish the efficacy of the method in the field and to investigate if it could be applied to other oilseed crops or successfully combined with different approaches to boost yields.

"Oilseed rape has become quite a profitable crop in recent years and the scale of cultivation in the U.K. has increased substantially," said Rothamsted Research's Pete Eastmond. "Farmers receive a bonus at market, based on the oil content of their seed, [so] if this technology translates from laboratory to field, we estimate it could be worth an extra 40 million pounds [$64 million] per year to farmers in the U.K. alone," he added.

Rapeseed is the U.K.'s major vegetable oil crop. The country's harvest declined 7% to 2.6 million tons in 2012 due to poor weather during the spring and summer, according to the farm ministry. A yield decrease of 13%, was mitigated by a 7.2% increase in planted area, to 755,000 hectares, after favorable planting conditions in autumn 2011.

Indeed, rapeseed has become extremely profitable for farmers in recent years as prices have been driven by the increasing popularity of rapeseed oil in cooking as its health benefits have become more widely known, it added.

Vegetable oils are obtained from the seeds and fruits of crop plants such as rapeseed, sunflower, soybean or palm and are a major global commodity. World production has surpassed 150 million metric tons a year and is predicted to rise by 50% within 20 years to meet growing demand.

Rothamsted Research said the experiment used RNA interference as a tool and was performed in collaboration with BASF Plant Science, a subsidiary of BASF SE. (BASFY).

Write to Michael Haddon at michael.haddon@dowjones.com or on Twitter @MichaelHaddonDJ

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BASF
08/15 BASF : Next-Generation Mosquito Nets On the Way
08/15 BASF : is lifting force majeure for dispersions, dispersion powders and hot melt..
08/07 BASF : Introduces first new class of public health insecticide for malaria preve..
08/07 LENZING : Group appoints Heiko Arnold CTO
08/06 BASF : Filling jobs toughest task for Tennessee manufacturers
08/05 GETTING THE DRIFT : Volatilization fogs blame issue
08/05 BASF : opens pharma formulations lab in India
08/04 BASF : It’s a very royal migration
08/04 BASF : Sandra Gonzalez Appointed to BASF Board
08/04 BASF : WakeEd Partnership Board of Directors Announces 2017-2018 Chair and Chair..
More news
News from SeekingAlpha
08/15 Global Oligopolies - Investing In Concentrated Businesses
08/14 MY JOURNEY TOWARDS FINANCIAL INDEPEN : 74 Stock June Portfolio Update; Buying AT..
08/11 GeoPark Discovered Oil In Argentina
08/10 GeoPark, Wintershall strike oil in Argentina
08/10 BASF SE (BASFY) Presents At Jefferies 13th Annual Industrials Conference - Sl..
Financials (€)
Sales 2017 63 000 M
EBIT 2017 7 342 M
Net income 2017 4 899 M
Debt 2017 14 255 M
Yield 2017 3,87%
P/E ratio 2017 15,21
P/E ratio 2018 14,54
EV / Sales 2017 1,41x
EV / Sales 2018 1,34x
Capitalization 74 332 M
Chart BASF
Duration : Period :
BASF Technical Analysis Chart | BAS | DE000BASF111 | 4-Traders
Technical analysis trends BASF
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 31
Average target price 91,3 €
Spread / Average Target 13%
EPS Revisions
Kurt W. Bock Chairman-Executive Board
Jürgen Hambrecht Chairman-Supervisory Board
Hans-Ulrich Engel Chief Financial Officer
Martin Brudermüller Chief Technology Officer
Michael Diekmann Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BASF-8.36%87 260
ROYAL DSM10.60%13 418